SKI Market

A+| A| A-|

Indian Indices

Sensex

74,068.45 1,372.06
( 1.89%)

Global Indices

Nasdaq

46,234.46 635.98
(1.39%)

Dow Jones

6,603.33 75.85
(1.16%)

Hang Seng

52,101.04 585.55
(1.14%)

Nikkei 225

9,942.10 47.95
(0.48%)

Forex

USD-INR

93.49 0.36
(0.39%)

EUR-INR

108.15 0.98
(0.91%)

GBP-INR

124.68 0.54
(0.44%)

JPY-INR

0.59 0.00
(0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

21.56

98767.58

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.31

Back

radhagobind commercial ltd

The Anup Engineering standalone net profit declines 0.87% in the September 2025 quarter

Nov 10,2025

Net profit of The Anup Engineering declined 0.87% to Rs 32.03 crore in the quarter ended September 2025 as against Rs 32.31 crore during the previous quarter ended September 2024. Sales rose 23.83% to Rs 232.64 crore in the quarter ended September 2025 as against Rs 187.87 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	232.64	187.87	24
OPM %	22.05	22.86	-
PBDT	49.55	43.38	14
PBT	43.01	37.68	14
NP	32.03	32.31	-1

74,068.45 1,372.06 ( 1.89%)

46,234.46 635.98 (1.39%)

6,603.33 75.85 (1.16%)

52,101.04 585.55 (1.14%)

9,942.10 47.95 (0.48%)

93.49 0.36 (0.39%)

108.15 0.98 (0.91%)

124.68 0.54 (0.44%)

0.59 0.00 (0.10%)